The New York Times’ daily email of its major stories comes organized by category - national, international, business, sports, arts, editorial and such.
Yesterday’s report that Genentech has come up with a promising drug to fight macular degeneration – the leading cause of blindness for older Americans - was classified under the "business" rubric.
Thus does the Times, innocently I suspect, reflect our society and comment on its values.